Literature DB >> 20508608

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?

Carlo Patrono, Colin Baigent.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20508608     DOI： 10.1038/nrcardio.2010.65

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  8 in total

1.  Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Carlo Patrono; Barry Coller; Garret A FitzGerald; Jack Hirsh; Gerald Roth
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

Review 2.  Platelet activation and atherothrombosis.

Authors:  Giovanni Davì; Carlo Patrono
Journal:  N Engl J Med       Date:  2007-12-13       Impact factor: 91.245

Review 3.  New P2Y(12) inhibitors.

Authors:  Marco Cattaneo
Journal:  Circulation       Date:  2010-01-05       Impact factor: 29.690

4.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.

Authors: 
Journal:  BMJ       Date:  2002-01-12

5.  Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial.

Authors:  F Gerald R Fowkes; Jacqueline F Price; Marlene C W Stewart; Isabella Butcher; Gillian C Leng; Alistair C H Pell; Peter A G Sandercock; Keith A A Fox; Gordon D O Lowe; Gordon D Murray
Journal:  JAMA       Date:  2010-03-03       Impact factor: 56.272

Review 6.  Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis.

Authors:  F G R Fowkes; G D Murray; I Butcher; C L Heald; R J Lee; L E Chambless; A R Folsom; A T Hirsch; M Dramaix; G deBacker; J-C Wautrecht; M Kornitzer; A B Newman; M Cushman; K Sutton-Tyrrell; F G R Fowkes; A J Lee; J F Price; R B d'Agostino; J M Murabito; P E Norman; K Jamrozik; J D Curb; K H Masaki; B L Rodríguez; J M Dekker; L M Bouter; R J Heine; G Nijpels; C D A Stehouwer; L Ferrucci; M M McDermott; H E Stoffers; J D Hooi; J A Knottnerus; M Ogren; B Hedblad; J C Witteman; M M B Breteler; M G M Hunink; A Hofman; M H Criqui; R D Langer; A Fronek; W R Hiatt; R Hamman; H E Resnick; J Guralnik; M M McDermott
Journal:  JAMA       Date:  2008-07-09       Impact factor: 56.272

7.  Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.

Authors:  Jeffrey S Berger; Mori J Krantz; John M Kittelson; William R Hiatt
Journal:  JAMA       Date:  2009-05-13       Impact factor: 56.272

8.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.